Publications

RPL22 is a tumor suppressor in MSI-high cancers and a splicing regulator of MDM4.

Weinstein HNW, Hu K, Fish L, et al. RPL22 is a tumor suppressor in MSI-high cancers and a splicing regulator of MDM4. Cell reports. 2024;43(8):114622. doi:10.1016/j.celrep.2024.114622

Yu GZ, Krentz NAJ, Bentley L, et al. Loss of reduces adipogenesis and improves insulin sensitivity in mouse and human adipocytes. bioRxiv : the preprint server for biology. 2024. doi:10.1101/2024.07.30.605923

Lee YU, Fox BW, Guo R, et al. Publisher Correction: Host-microbe interactions rewire metabolism in a C. elegans model of leucine breakdown deficiency. Nature metabolism. 2024. doi:10.1038/s42255-024-01127-3

Bick F, Gómez CMB, Lammens I, et al. Interleukin-2 family cytokines IL-9 and IL-21 differentially regulate innate and adaptive type 2 immunity in asthma. The Journal of allergy and clinical immunology. 2024. doi:10.1016/j.jaci.2024.07.024

Schipper M, Ulirsch J, Posthuma D, Ripke S, Heilbron K. Simplifying causal gene identification in GWAS loci. medRxiv : the preprint server for health sciences. 2024. doi:10.1101/2024.07.26.24311057

Weinstein HNW, Hu K, Fish L, et al. RPL22 is a tumor suppressor in MSI-high cancers and a splicing regulator of MDM4. Cell reports. 2024;43(8):114622. doi:10.1016/j.celrep.2024.114622

Nilsson M, Kozyrev S V, Lindblad-Toh K, Rönnberg H, Hansson-Hamlin H. In sickness and health - a questionnaire based study regarding immune mediated diseases and neoplasia in Swedish Nova Scotia Duck Tolling Retrievers. Acta veterinaria Scandinavica. 2024;66(1):39. doi:10.1186/s13028-024-00761-x

Schipper M, Ulirsch J, Posthuma D, Ripke S, Heilbron K. Simplifying causal gene identification in GWAS loci. medRxiv : the preprint server for health sciences. 2024. doi:10.1101/2024.07.26.24311057

Duggan MR, Peng Z, Sipilä PN, et al. Proteomics identifies potential immunological drivers of postinfection brain atrophy and cognitive decline. Nature aging. 2024. doi:10.1038/s43587-024-00682-4

ӳ����ý

Publications

ӳ��ý